Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
JAMA Oncology2022Vol. 9(1), pp. 112–112
Citations Over TimeTop 1% of 2022 papers
Linda M. Liau, Keyoumars Ashkan, Steven Brem, Jian Campian, John Trusheim, Fábio M. Iwamoto, David D. Tran, George Ansstas, Charles Cobbs, Jason Heth, Michael Salacz, Stacy D. D’Andre, Robert Aiken, Yaron A. Moshel, Joo Yeon Nam, Clement Pillainayagam, Stephanie A. Wagner, Kevin A. Walter, Rubina Chaudhary, Samuel Goldlust, Ian Lee, Daniela A. Bota, Heinrich Elinzano, Jai Grewal, Kevin O. Lillehei, Tom Mikkelsen, Tobias Walbert, Steven R. Abram, Andrew Brenner, Matthew G. Ewend, Simon Khagi, Darren Lovick, Jana Portnow, Lyndon Kim, William G. Loudon, Nina Martinez, Reid C. Thompson, David Avigan, Karen Fink, Francois J. Geoffroy, Pierre Giglio, Oleg Gligich, Dietmar Krex, Scott Lindhorst, Jose Lutzky, Hans-Joerg Meisel, Minou Nadji‐Ohl, Lhagva Sanchin, Andrew E. Sloan, Lynne P. Taylor, Julian K. Wu, Erin Dunbar, Arnold B. Etame, Santosh Kesari, David Mathieu, David Piccioni, David S. Baskin, Michel Lacroix, Sven-Axel May, Pamela New, Timothy Pluard, Steven A. Toms, Victor Tse, Scott Peak, John L. Villano, James Battiste, Paul Mulholland, Michael Pearlman, Kevin Petrecca, Michael Schulder, Robert M. Prins, Alton L. Boynton, Marnix L. Bosch
Abstract
ClinicalTrials.gov Identifier: NCT00045968.
Related Papers
- → 12-Cycle of Temozolomide Treatment is not Superior To 6-Cycle of Treatment in Glioblastoma Multiforme(2020)1 cited
- → EP-1204: Limited margin radiotherapy and temozolomide for glioblastoma multiforme: pattern of failure(2018)1 cited
- → 42 A novel approach using accelerated hypo-fractionation-IMRT (AH-IMRT) and temozolomide (TMZ) in patients with glioblastoma multiforme (GBM)(2006)
- → Evaluation of tolerance of Temozolomide in different strategies for management of the older person with glioblastoma(2013)
- 2. Glioblastoma再発に対しTemozolomideを使用した１例(第35回群馬脳腫瘍研究会)(2009)